Quantitative magnetic resonance imaging biomarkers in oncological clinical trials: Current techniques and standardization challenges-Reference-Cited by-同舟云学术

Quantitative magnetic resonance imaging biomarkers in oncological clinical trials: Current techniques and standardization challenges

Published:2017-03 Issue:1 Volume:3 Page:8-20
ISSN:2095-882X
Container-title:Chronic Diseases and Translational Medicine
language:en
Short-container-title:Chronic Diseases and Translational Medicine

Author:

Deng Jie,Wang Yi

Publisher

Elsevier BV

Subject

General Medicine

Reference124 articles.

1. American Cancer Society. Global Cancer Facts & Figures. https://www.cancer.org/research/cancer-facts-statistics/global.html. Accessed January 1, 2017.

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Imaging biomarker roadmap for cancer studies;O'Connor;Nat Rev Clin Oncol,2017

4. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Cancer,2009

5. Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?;Afaq;Cancer Imaging,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality control of quantitative diffusion-weighted magnetic resonance imaging: metrological problems;Izmeritel`naya Tekhnika;2024-06-21

2. Magnetic resonance metrics for identification of cuprizone-induced demyelination in the mouse model of neurodegeneration: a review;Magnetic Resonance Materials in Physics, Biology and Medicine;2024-04-18

3. A fast protocol for multicenter and multiparametric quantitative MRI studies in brain tumor patients using vendor sequences;Neuro-Oncology Advances;2024-01-01

4. The role of clinical imaging in oncology drug development: progress and new challenges;The British Journal of Radiology;2023-10

5. Tailored magnetic resonance fingerprinting;Magnetic Resonance Imaging;2023-06